Literature DB >> 11035984

Advances in uterine leiomyoma research: the progesterone hypothesis.

M S Rein1.   

Abstract

Uterine leiomyomas are monoclonal tumors. However, the factors involved in their initiation and growth remain poorly understood. The neoplastic transformation of myometrium to leiomyoma likely involves somatic mutations of normal myometrium and the complex interactions of sex steroids and local growth factors. Traditionally, estrogen has been considered the major promoter of myoma growth. The purpose of this review is to highlight the biochemical, histologic, and clinical evidence that supports an equally important role for progesterone in the growth of uterine myomas. Biochemical studies suggest that progesterone, progestins, and the progesterone receptor modulate myoma mitotic activity. A hypothesis to explain the pathogenesis of myomas is presented.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035984     DOI: 10.1289/ehp.00108s5791

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  24 in total

1.  In vitro responsiveness of human post-menopausal myometrium to endothelin-1 and ovarian steroids.

Authors:  E Domali; P A Molyvdas; I E Messinis
Journal:  J Endocrinol Invest       Date:  2005-06       Impact factor: 4.256

Review 2.  Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy.

Authors:  Mostafa A Borahay; Ayman Al-Hendy; Gokhan S Kilic; Darren Boehning
Journal:  Mol Med       Date:  2015-04-13       Impact factor: 6.354

3.  Postpartum factors and natural fibroid regression.

Authors:  Shannon K Laughlin; Katherine E Hartmann; Donna D Baird
Journal:  Am J Obstet Gynecol       Date:  2011-04-14       Impact factor: 8.661

4.  Uterine leiomyomata in a cohort of Great Lakes sport fish consumers.

Authors:  Anissa Lambertino; Mary Turyk; Henry Anderson; Sally Freels; Victoria Persky
Journal:  Environ Res       Date:  2011-02-09       Impact factor: 6.498

5.  Depressive symptoms and risk of uterine leiomyomata.

Authors:  Lauren A Wise; Se Li; Julie R Palmer; Lynn Rosenberg
Journal:  Am J Obstet Gynecol       Date:  2014-12-13       Impact factor: 8.661

6.  History of uterine leiomyoma and risk of endometrial cancer in black women.

Authors:  Lauren A Wise; Todd R Sponholtz; Lynn Rosenberg; Lucile L Adams-Campbell; Wendy Kuohung; Michael P LaValley; Julie R Palmer
Journal:  Cancer Causes Control       Date:  2016-02-29       Impact factor: 2.506

7.  Hyperplasia and fibrosis in mice with conditional loss of the TSC2 tumor suppressor in Müllerian duct mesenchyme-derived myometria.

Authors:  Tomoko Kaneko-Tarui; Arno E Commandeur; Amanda L Patterson; Justin L DeKuiper; David Petillo; Aaron K Styer; Jose M Teixeira
Journal:  Mol Hum Reprod       Date:  2014-09-04       Impact factor: 4.025

Review 8.  Leiomyomata uteri: hormonal and molecular determinants of growth.

Authors:  Richard Enrique Blake
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

9.  Association of exposure to phthalates with endometriosis and uterine leiomyomata: findings from NHANES, 1999-2004.

Authors:  Jennifer Weuve; Russ Hauser; Antonia M Calafat; Stacey A Missmer; Lauren A Wise
Journal:  Environ Health Perspect       Date:  2010-02-25       Impact factor: 9.031

Review 10.  Epidemiology of Uterine Fibroids: From Menarche to Menopause.

Authors:  Lauren A Wise; Shannon K Laughlin-Tommaso
Journal:  Clin Obstet Gynecol       Date:  2016-03       Impact factor: 2.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.